Position in QGEN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$728,237
+$178,568 QoQ
Shares Held
18,625
+35.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#175
of 332 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $40,569,660 across 16 Diagnostics & Research names. QGEN ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,026 | $6,530,715 | |
| 2 | ILMN |
Illumina, Inc.
|
22,808 | $4,010,330 | |
| 3 | DHR |
Danaher Corp /De/
|
19,635 | $3,740,074 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,051 | $3,190,059 | |
| 5 | A |
Agilent Technologies, Inc.
|
23,182 | $3,079,265 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
13,010 | $2,950,537 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,384 | $2,779,276 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
4,777 | $2,514,803 |
All Filings in QGEN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,237 | 18,625 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $549,669 | 13,728 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $636,955 | 14,164 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $518,109 | 11,596 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||